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Abstract: Inadequate iodine status affects the synthesis of the thyroid hormones and may impair brain
development in fetal life. The aim of this study was to explore the association between maternal iodine
status in pregnancy measured by urinary iodine concentration (UIC) and child neurodevelopment at
age 6, 12 and 18 months in a population-based cohort. In total, 1036 families from nine locations in
Norway were enrolled in the little in Norway cohort. The present study includes n = 851 mother-child
pairs with singleton pregnancies, no use of thyroid medication in pregnancy, no severe genetic
disorder, data on exposure (UIC) in pregnancy and developmental outcomes (Bayley Scales of Infant
and Toddler Development, third edition). Data collection also included general information from
questionnaires. We examined associations between UIC (and use of iodine-containing supplements)
and repeated measures of developmental outcomes using multivariable mixed models. The median
UIC in pregnancy was 78 µg/L (IQR 46–130), classified as insufficient iodine intake according to the
WHO. Eighteen percent reported use of iodine-containing multisupplements. A UIC below ~100 was
associated with reduced receptive (p = 0.025) and expressive language skills (p = 0.002), but not with
reduced cognitive or fine- and gross motor skills. Maternal use of iodine-containing supplements was
associated with lower gross motor skills (b = −0.18, 95% CI = −0.33, −0.03, p = 0.02), but not with
the other outcome measures. In conclusion, an insufficient iodine intake in pregnancy, reflected in a
UIC below ~100 µg/L, was associated with lower infant language skills up to 18 months. The use of
iodine-containing supplements was not associated with beneficial effects.
Keywords: Bayley; cohort; pregnancy; iodine status; iodine supplementation; infants; ICP-MS;
mild to moderate iodine deficiency; neurodevelopment; urinary iodine concentration
1. Introduction
Iodine deficiency (ID) is considered one of the most common nutritional disorders globally and is
the world’s largest single cause of preventable brain impairment [1]. Infants and pregnant women are
particularly vulnerable population groups [2], as ID may impair normal growth and development of
the child, especially affecting brain development [3].
Nutrients 2018, 10, 1270; doi:10.3390/nu10091270 www.mdpi.com/journal/nutrients
Nutrients 2018, 10, 1270 2 of 13
Iodine is an essential nutrient for the synthesis of the thyroid hormones triiodothyronine (T3)
and thyroxine (T4). Dietary iodine is rapidly absorbed and the thyroid gland is dependent on
regular and adequate supply through the diet in order to produce these vital hormones [4]. In the
fetal brain, inadequate thyroid hormone levels impair differentiation, maturation, cell migration,
and myelination [3]. The iodine turnover during pregnancy is increased because the mother synthesizes
approximately 50% more T4 to maintain maternal euthyroidism and transfer thyroid hormones to the
fetus, and because iodine needs to be transferred to the fetus for fetal thyroid hormone production.
In addition, the renal iodine clearance increases during pregnancy [5,6]. Critically low levels of thyroid
hormones, associated with severe ID, cause neurological damage to the brain, particularly during the
fetal and neonatal period, which can result in delayed motor and mental development [7–10]. Mild to
moderate ID may also result in impaired mental development [11–14].
The World Health Organization (WHO) estimates that women in 21 European countries have
inadequate iodine intake in pregnancy (defined as a median UIC < 150 µg/L), while only women
in 10 countries are considered to have sufficient intake. No data are available in the remaining
23 countries [15]. In Norway, the public health focus on iodine has moved from endemic ID in
certain inland areas at the beginning of the 20th century to the assumption of iodine sufficiency since
1950 [16]. However, there has never been a systematic monitoring program in Norway to confirm this
assumption. The estimated iodine intake in the Norwegian population among adults and children
shows that the intake of milk, dairy products and seafood contributes with ~80% of the total iodine
intake [17,18]. This indicates that certain groups of the population may be at risk of a low iodine intake,
e.g., subjects with allergy to milk or fish, vegetarians who do not consume fish, milk and dairy products
(vegans), and others with low consumption of milk and fish. Other vulnerable groups that might have
low iodine intake are pregnant and lactating women since there is a higher recommended intake of
iodine during this period of life [19–21]. Data from the Norwegian Mother and Child Cohort Study
(MoBa) (n = 61,904) showed inadequate iodine intake in pregnant Norwegian women and the authors
suggested that sub-optimal iodine intake is a health concern in Norwegian pregnant women [22].
Several recent publications have documented mild to moderate iodine deficiency in pregnant women
in different parts of Norway, with a median UIC of 92 µg/L (n = 777) in the Oslo area [23] and a
median UIC of 75 µg/L (n = 197) in the Tromsø area [24]. Additionally, published results from the
Litle in Norway cohort showed a median UIC of 85 µg/L (n = 954) in pregnancy [25]. Further studies
and a better understanding of the consequences of mild to moderate ID in pregnancy on subsequent
neurodevelopment in infancy and toddlerhood are scarce. Therefore, with samples and data from the
Little in Norway study (LiN), the primary aim of this study was to explore whether maternal iodine
status in pregnancy, measured by a spot UIC, was associated with child neurodevelopment up to age
18 months. A secondary aim was to investigate the potential impact of maternal iodine supplement
use in pregnancy on the same outcome measures.
2. Materials and Methods
2.1. Study Design, Participants and Enrolment
The LiN study is a population-based prospective cohort established to investigate pre- and
postnatal risk factors influencing developmental plasticity from pregnancy to age 18 months. Pregnant
women were enrolled at nine public health clinics for mothers and children across all four Norwegian
health regions. The clinics were chosen after considering demographic characteristics and size of
the population to include participants from both cities and rural districts with a wide distribution
of socioeconomic conditions. From each site, one public health care nurse was trained as a research
assistant. Enrolment started in September 2011 and ended October 2012. Midwives at the public
health clinics approached pregnant women 16–26 weeks gestation with an invitation to participate;
however, some women were asked as late as weeks 31–34. Data collection up to age 18 months ended in
November 2014. Attrition analysis for the mothers in the LiN study is reported by Fredriksen et al. [26].
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Inclusion criteria for analysis in the present study were available data on UIC and on child development,
singleton pregnancy, no thyroid medication in pregnancy, and no severe genetic disorder (Figure 1).
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2.2. Data Collection
Participation entailed donating a spot urine sample for analysis of UIC, responding to
questionnaires during pregnancy, and meeting with a research assistant after delivery for assessment
of child neurodevelopment at 6, 12 and 18 months. The spot urine sample could be collected at
home or on site, and be taken at any time. Details regarding time of sampling has been described
elsewhere [25]. Data were collected by the research assistants based on interview of the parents, and
by testing the child; through self-report questionnaires completed at the public health clinics; and
self-report questionnaires completed at home. Details regarding data collection and the questionnaires
have been described elsewhere [25,27]
2.3. Exposure Variables—Urinary Iodine Concentration and Use of Iodine Containing Supplements
Non-fasting spot-urine samples from the mothers were collected at the first (23.7 ± 5.0 gestational
week) and the third (26.4 ± 1.6 gestational week) meeting with the research assistant at the public
health clinic. The urine sample collected at the first meeting was preferably used in analysis (n = 851;
if missing, urine sample collected at the third meeting was used (n = 7)). Urinary iodine is regarded as
a good population biomarker of iodine intake because more than 92% of ingested iodine is excreted in
the urine within 24–48 h [6]. Because it is impractical to collect 24-h samples in field studies, UIC were
measured in spot urine collections [2]. Maternal hydration status affects spot-urine concentrations,
and since creatinine is excreted in urine at a fairly constant rate, UIC per gram creatinine is often used
with the aim to remove variation in UIC due to hydration. UIC in µg/L was used as the primary
exposure since creatinine excretion varies in pregnancy with regards to gestational age, maternal age
and body composition [6]. Additionally, as alternative exposure measures, we have included, in the
online supplementary material, analyses of (1) UIC in µg/g creatinine and (2) residuals of UIC in µg/L
after regressing log UIC on log urinary creatinine.
Questions on supplement use were embedded in a short web-based food frequency questionnaire
explained elsewhere [25]. Iodine, ranging from 150 µg to 200 µg, was used in combination with other
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micronutrients, vitamins, with or without omega-3 fatty acids, by all users. Use of iodine supplement
was coded yes or no employing compiled data from frequency questions (‘never’ was coded ‘no’,
while ‘1–3 times per month’, ‘1–3 times per week’, ‘4–6 times per week’, and ‘daily’ were coded ‘yes’).
2.4. Outcome Variables—Neurocognitive Development
The cognitive, language, and motor scales of the Bayley Scales of Infant and Toddler Development,
third edition (Bayley-III) were used to assess the infants’ developmental skills [28]. Bayley-III is an
individually administered instrument designed to measure the developmental functioning of infants
and toddlers, especially suited to detect developmental delays. The Bayley-III is commonly regarded
as the gold standard in infant development assessment, provide good reliability and validity, and is
often used as the instrument to validate other instruments [29,30]. At six and 12 months, the screening
version of the test was used measuring all five domains: cognitive, receptive communication,
expressive communication, gross motor and fine motor. At 18 months, the full-scale version was
used measuring cognitive and language skills. The screening version is shorter than the full version
comprising a selection of the test items employed in the full version. The two language scales
are receptive communication, measuring verbal comprehension; and expressive communication,
such as babbling, utterances, and gestures. Health care nurses, trained under supervision of clinical
psychologists specialized in infant and child development, administered the test at the well-baby
clinics. The parents were present in the room but instructed not to interfere with the testing.
2.5. Covariates
When recruited in pregnancy, participants completed a questionnaire onsite at their local public
health clinic and a questionnaire at home including questions on age, pre-pregnancy weight and height,
parity, education, marital status, use of iodine containing supplements, use of omega-3 supplements in
pregnancy, and daily smoking in pregnancy [25]. When infants were born, public health care nurses
recorded data including child gender.
2.6. Laboratory Analysis
Urine was collected at each site and stored at −18 ◦C pending analysis. Prior to analysis,
the urine samples were defrosted in a refrigerator. UIC was determined by inductively coupled
plasma mass-spectrometry (ICP-MS) after dilution with 1% tetrametylammonium hydroxid (TMAH).
Prior to the analysis the samples were filtrated using a sterile membrane filter (0.45 µm pore size)
and transferred to tubes appropriate for the analysis by the Agilent 7500 for ICP-MS at Institute of
Marine Research, Bergen, Norway. Samples were analysed against a urine calibration curve (standard
addition curve) to measure the unknown iodine concentration (127I) in the collected urine samples.
Accuracy was verified with certified reference material; Seronorm Trace Elements Urine (Nycomed
Pharma, Norway), iodine content: 84 µg/L (range, 72–96 µg/L) and 304 µg/L (range: 260–348 µg/L).
In addition to UIC, I/Cr ratio and estimated 24 h UIE were determined. Determination of urinary
creatinine concentration was analysed using the MAXMAT PL II multidisciplinary diagnostic platform
with creatinine PAP kit [31].
2.7. Ethics
The trial complies with the Declaration of Helsinki and was commenced after approval by the
Regional Committees for Medical and Health Research Ethics (2011/560 REK South-East). Written
informed consent was obtained from the participants who could withdraw from the study at any time.
2.8. Statistical Analyses
Continuous variables are expressed as mean with SD for normally distributed data, as median
with interquartile range (IQR) for non-normally distributed data, and categorical variables as numbers
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and percentages. ANOVA was used to compare numerical data and Pearson
USV Symbol Macro(s) Description
04C5 Ӆ \CYRLDSC CYRILLIC CAPITAL LETTER EL WITH TAIL
04C6 ӆ \cyrldsc CYRILLIC SMALL LETTER EL WITH TAIL
04C7 Ӈ \CYRNHK CYRILLIC CAPITAL LETTER EN WITH HOOK
04C8 ӈ \cyrnhk CYRILLIC SMALL LETTER EN WITH HOOK
04CB Ӌ \CYRCHLDSC CYRILLIC CAPITAL LETTER KHAKASSIAN CHE
04CC ӌ \cyrchldsc CYRILLIC SMALL LETTER KHAKASSIAN CHE
04CD Ӎ \CYRMDSC CYRILLIC CAPITAL LETTER EM WITH TAIL
04CE ӎ \cyrmdsc CYRILLIC SMALL LETTER EM WITH TAIL
04D0 Ӑ \U{\CYRA} CYRILLIC CAPITAL LETTER A WITH BREVE
04D1 ӑ \U{\cyra} CYRILLIC SMALL LETTER A WITH BREVE
04D2 Ӓ \"{\CYRA} CYRILLIC CAPITAL LETTER A WITH DIAERESIS
04D3 ӓ \"{\cyra} CYRILLIC SMALL LETTER A WITH DIAERESIS
04D4 Ӕ \CYRAE CYRILLIC CAPITAL LIGATURE A IE
04D5 ӕ \cyrae CYRILLIC SMALL LIGATURE A IE
04D6 Ӗ \U{\CYRE} CYRILLIC CAPITAL LETTER IE WITH BREVE
04D7 ӗ \U{\cyre} CYRILLIC SMALL LETTER IE WITH BREVE
04D8 Ә \CYRSCHWA CYRILLIC CAPITAL LETTER SCHWA
04D9 ә \cyrschwa CYRILLIC SMALL LETTER SCHWA
04DA Ӛ \"{\CYRSCHWA} CYRILLIC CAPITAL LETTER SCHWA WITH DIAERESIS
04DB ӛ \"{\cyrschwa} CYRILLIC SMALL LETTER SCHWA WITH DIAERESIS
04DC Ӝ \"{\CYRZH} CYRILLIC CAPITAL LETTER ZHE WITH DIAERESIS
04DD ӝ \"{\cyrzh} CYRILLIC SMALL LETTER ZHE WITH DIAERESIS
04DE Ӟ \"{\CYRZ} CYRILLIC CAPITAL LETTER ZE WITH DIAERESIS
04DF ӟ \"{\cyrz} CYRILLIC SMALL LETTER ZE WITH DIAERESIS
04E0 Ӡ \CYRABHDZE CYRILLIC CAPITAL LETTER ABKHASIAN DZE
04E1 ӡ \cyrabhdze CYRILLIC SMALL LETTER ABKHASIAN DZE
04E2 Ӣ \={\CYRI} CYRILLIC CAPITAL LETTER I WITH MACRON
04E3 ӣ \={\cyri} CYRILLIC SMALL LETTER I WITH MACRON
04E4 Ӥ \"{\CYRI} CYRILLIC CAPITAL LETTER I WITH DIAERESIS
04E5 ӥ \"{\cyri} CYRILLIC SMALL LETTER I WITH DIAERESIS
04E6 Ӧ \"{\CYRO} CYRILLIC CAPITAL LETTER O WITH DIAERESIS
04E7 ӧ \"{\cyro} CYRILLIC SMALL LETTER O WITH DIAERESIS
04E8 Ө \CYROTLD CYRILLIC CAPITAL LETTER BARRED O
04E9 ө \cyrotld CYRILLIC SMALL LETTER BARRED O
04EA Ӫ \"{\CYROTLD} CYRILLIC CAPITAL LETTER BARRED O WITH DIAERESIS
04EB ӫ \"{\cyrotld} CYRILLIC SMALL LETTER BARRED O WITH DIAERESIS
04EC Ӭ \"{\CYREREV} CYRILLIC CAPITAL LETTER E WITH DIAERESIS
04ED ӭ \"{\cyreref} CYRILLIC SMALL LETTER E WITH DIAERESIS
04EE Ӯ \={\CYRU} CYRILLIC CAPITAL LETTER U WITH MACRON
04EF ӯ \={\cyru} CYRILLIC SMALL LETTER U WITH MACRON
04F0 Ӱ \"{\CYRU} CYRILLIC CAPITAL LETTER U WITH DIAERESIS
04F1 ӱ \"{\cyru} CYRILLIC SMALL LETTER U WITH DIAERESIS
04F2 Ӳ \H{\CYRU} CYRILLIC CAPITAL LETTER U WITH DOUBLE ACUTE
04F3 ӳ \H{\cyru} CYRILLIC SMALL LETTER U WITH DOUBLE ACUTE
04F4 Ӵ \"{\CYRCH} CYRILLIC CAPITAL LETTER CHE WITH DIAERESIS
04F5 ӵ \"{\cyrch} CYRILLIC SMALL LETTER CHE WITH DIAERESIS
04F6 Ӷ \CYRGDSC CYRILLIC CAPITAL LETTER GHE WITH DESCENDER
04F7 ӷ \cyrgdsc CYRILLIC SMALL LETTER GHE WITH DESCENDER
04F8 Ӹ \"{\CYRERY} CYRILLIC CAPITAL LETTER YERU WITH DIAERESIS
04F9 ӹ \"{\cyrery} CYRILLIC SMALL LETTER YERU WITH DIAERESIS
04FC Ӽ \CYRHHK CYRILLIC CAPITAL LETTER HA WITH HOOK
04FD ӽ \cyrhhk CYRILLIC SMALL LETTER HA WITH HOOK
05C3 ׃ \sofpasuq HEBREW PUNCTUATION SOF PASUQ
05D0 א \textalef
\hebalef
HEBREW LETTER ALEF
23
2 to compare categorical
data in Table 1 on background characteristics.
Missing data on pre pregnancy body mass index (BMI) (n = 155 (18%)) were imputed by multiple
imputation by chained equations in STATA, and 50 imputed datasets were generated for analyses.
The imputation models included all variables included in the final analyses and was done separately
for different exposures (UIC per liter, UIC per gram creatinine, UIC adjusted for creatinine by the
residual method, and iodine supplement use in pregnancy). More details about the imputation models
are provided in Method S1.
Multivariable mixed models were used to explore associations between exposures and repeated
measures of cognitive score, receptive language skills, expressive language skills, fine motor skills,
and gross motor skills. Associations between UIC and outcomes were modelled flexibly by use of
restricted cubic splines (three knot positions, at percentiles 10, 50, and 90 of UIC). Potential time-varying
effects were explored by testing interaction terms of exposure and time equal to zero. Outcome
measures were standardized at each time point to obtain similar scales for the measurements. Since the
mean and the variance at each time point by design were equal, generalized estimating equations
were used to estimate the marginal effects, and an unstructured correlation matrix was specified to
account for correlations between the repeated measurements. Results were reported as estimated
mean across measurement occasions including 95% robust confidence intervals (CI). P-values for the
overall associations of UIC and outcomes were calculated by testing all spline-coefficients equal to
zero, and non-linearity by testing the second spline coefficient equal to zero.
We adjusted for potential confounding factors including maternal age, pre -pregnancy BMI,
maternal education, marital status, parity, smoking in pregnancy, and included child gender,
an important determinant of the outcomes, to increase the precision of the estimates. The sensitivity
analysis on iodine containing supplement use also included use of omega-3 supplements as a covariate.
Two-tailed p < 0.05 was considered statistically significant. Statistical analyses of background
characteristics were performed using Statistical Package for the Social Sciences (SPSS® Statistics Version
24). All remaining analyses were performed in STATA (version 15.0; Stata Corp., College Station, TX,
USA). The package postrcspline for STATA was used for graphing of the flexible models [32].
3. Results
3.1. Background Characteristics
Mean gestational week for collection of urine sample used in the analyses was 23.7 ± 4.9.
The median UIC in pregnancy was 78 µg/L (IQR 46–130, min 4, max 750). In total, 676 (79%)
women had a UIC of less than 150 µg/L and 242 (28%) women had a UIC of less than 50 µg/L
(Table 1). The ages (mean ± SD, (min-max)) in infancy and toddlerhood at the three time points
for neurodevelopmental assessment were 6.1 ± 0.4 (4.4–8.2), 12.2 ± 0.6 (10.1–15.6), and 18.4 ± 0.8
(16.7–22.2) months, respectively. There was minimal loss to follow up (mean number of assessments
were 2.7 of 3 for cognitive scores and language scores, and 1.9 of 2 for fine and gross motor scores).
In total, 155 (18%) women reported use of an iodine-containing supplement during the last three
months before the spot-UIC was collected in pregnancy. Of the supplement users, daily use was
reported by 69%, 4–6 days per week by 13.5%, 1–3 times per week by 12.3%, and, 1–3 times per
month by 5.2%. The median (IQR) dose of iodine supplementation was 175 (25) µg. Considering the
individual intake frequency this gives a median estimated daily intake of 150 (50) µg iodine from
supplements. UIC was higher in supplement users (median 92 µg/L) compared to non-supplement
users (median 77 µg/L), p < 0.001) (Table 1).
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Table 1. Characteristics of the study population by UIC in pregnancy and by use of iodine-containing supplements.
Characteristic UIC in Pregnancy (µg/L) Iodine Supplement
n All <50 50–149 ≥150 p-Value 1 Non Users Users p-Value 2
n 851 851 242 434 175 658 155
UIC, µl/L 3,4, 851 78 (46,130) 33 (24,42) 83 (66,110) 200 (160,270) 77 (50,120) 92 (56,200) <0.001
UIC, µg/g creatinine 3,4 851 82 (53,124) 57 (38,86) 77 (53,110) 143 (105,222) 75 (44,120) 98 (59,190) <0.001
UIC~Cr, µg/l 3,4 851 81 (58,120) 63 (45,77) 80 (58,102) 178 (147,238) 78 (57,109) 110 (74,178) <0.001
Age of mother (ys), mean ± SD 851 30.3 ± 4.7 30.2 ± 7.4 30.2 ± 4.5 30.7 ± 5.1 0.39 30.3 ± 4.6 30.2 ± 4.9 0.71
BMI, mean ± SD 696 23.4 ± 4.0 23.1 ± 3.7 23.6 ± 4.1 23.5 ± 4.3 0.40 23.4 ± 3.8 23.6 ± 4.8 0.60
Parity, % 851 0.15 0.38
Nulliparous 471 55 60 54 53 55 61
Primiparous 275 32 26 35 34 33 28
Multiparous 105 12 14 11 13 12 10
Maternal education, % 851 0.39 0.37
Low (≤ 12 years) 182 21 24 22 16 21 17
Medium (13–16 years) 323 38 38 37 41 38 43
High (≥ 17 years) 346 41 39 41 43 41 41
Maternal cohabitation, % 851 0.71 0.23
Yes 829 97 97 97 98 97 99
No 22 2.6 2.9 2.8 1.7 3.0 1.3
Iodine containing supplement, % 813
Yes 155 19 12 18 31 <0.001 Na Na Na
No 658 81 88 82 69 Na Na
Daily smoking in pregnancy, % 851 0.30 0.76
Yes 24 2.8 4.1 2.1 2.9 97 97
No 827 97 96 98 97 3.0 2.6
Infant gender, % 851 0.60 0.69
Boys 433 51 50 52 49 52 50
Girls 418 49 50 48 51 48 50
1 Comparison of numerical data with ANOVA and categories with pearson
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04F0 Ӱ \"{\CYRU} CYRILLIC CAPITAL LETTER U WITH DIAERESIS
04F1 ӱ \"{\cyru} CYRILLIC SMALL LETTER U WITH DIAERESIS
04F2 Ӳ \H{\CYRU} CYRILLIC CAPITAL LETTER U WITH DOUBLE ACUTE
04F3 ӳ \H{\cyru} CYRILLIC SMALL LETTER U WITH DOUBLE ACUTE
04F4 Ӵ \"{\CYRCH} CYRILLIC CAPITAL LETTER CHE WITH DIAERESIS
04F5 ӵ \"{\cyrch} CYRILLIC SMALL LETTER CHE WITH DIAERESIS
04F6 Ӷ \CYRGDSC CYRILLIC CAPITAL LETTER GHE WITH DESCENDER
04F7 ӷ \cyrgdsc CYRILLIC SMALL LETTER GHE WITH DESCENDER
04F8 Ӹ \"{\CYRERY} CYRILLIC CAPITAL LETTER YERU WITH DIAERESIS
04F9 ӹ \"{\cyrery} CYRILLIC SMALL LETTER YERU WITH DIAERESIS
04FC Ӽ \CYRHHK CYRILLIC CAPITAL LETTER HA WITH HOOK
04FD ӽ \cyrhhk CYRILLIC SMALL LETTER HA WITH HOOK
05C3 ׃ \sofpasuq HEBREW PUNCTUATION SOF PASUQ
05D0 א \textalef
\hebalef
HEBREW LETTER ALEF
23
2. 2 Comparison of numerical data with student’s t-test (UI -measures were log transformed) and categories
with pearson
USV Symbol Macro(s) Description
04C5 Ӆ \CYRLDSC CYRILLIC CAPITAL LETTER EL WITH TAIL
04C6 ӆ \cyrldsc CYRILLIC SMALL LETTER EL WIT TAIL
04C7 Ӈ \CYRNHK CYRILLIC CAPITAL LETTER EN WITH HOOK
04C8 ӈ \cyrnhk CYRILLIC SMALL LETTER EN WIT HOOK
04CB Ӌ \CYRCHLDSC YRILLIC CAPITAL LETTER KHAKASSIAN CHE
04CC ӌ \cyrchldsc CYRILLIC SMALL LETTER KHAKASSIAN CHE
04CD Ӎ \CYRMDSC CYRILLIC CAPITAL LETTER EM WITH TAIL
04CE ӎ \cyrmdsc CYRILLIC SMALL LETTER EM WITH T IL
04D0 Ӑ \U{\CYRA} CYRILLIC CAPITAL LETTER A WITH BREVE
04D1 ӑ \U{\cyra} CYRILLIC SMALL LETTER A WITH B EVE
04D2 Ӓ \"{\CYRA} CYRILLIC CAPITAL LETTER A WITH DIAERESIS
04D3 ӓ \"{\cyra} CYRILLIC SMALL LETTER A WITH DIAERESIS
04D4 Ӕ \CYRAE CYRILLIC CAPITAL LIGATURE A IE
04D5 ӕ \cyrae CYRILLIC SMALL LIGATURE A IE
04D6 Ӗ \U{\CYRE} CYRILLIC CAPITAL LETTER IE WITH BREVE
04D7 ӗ \U{\cyre} CYRILLIC SMALL LETTER IE WITH BREVE
04D8 Ә \CYRSCHWA CYRILLIC CAPITAL LETTER SCHWA
04D9 ә \cyrschwa CYRILLIC SMALL LETTER SCHWA
04DA Ӛ \"{\CYRSCHWA} CYRILLIC CAPITAL LETTER SCHWA WITH DIAERESIS
04DB ӛ \"{\cyrschwa} YRILLIC SMALL LETTER SCHWA WITH DIAERESIS
04DC Ӝ \"{\CYRZH} CYRILLIC CAPITAL LETTER ZHE WITH DIAERESIS
04DD ӝ \"{\cyrzh} CYRILLIC SMALL LETTER ZHE WITH DIAERESIS
04DE Ӟ \"{\CYRZ} CYRILLIC CAPITAL LETTER ZE WITH DIAERESIS
04DF ӟ \"{\cyrz} CYRILLIC SMALL LETTER ZE WITH DIAERESIS
04E0 Ӡ \CYRABHDZE CYRILLIC CAPITAL LETTER ABKHASIAN DZE
04E1 ӡ \cyrabhdze CYRILLIC SMALL LETTER ABKHASIAN DZE
04E2 Ӣ \={\CYRI} CYRILLIC CAPITAL LETTER I WITH MACRON
04E3 ӣ \={\cyri} CYRILLIC SMALL LETTER I WITH MACRON
04E4 Ӥ \"{\CYRI} CYRILLIC CAPITAL LETTER I WITH DIAERESIS
04E5 ӥ \"{\cyri} CYRILLIC SMALL LETTER I WITH DIAERESIS
04E6 Ӧ \"{\CYRO} CYRILLIC CAPITAL LETTER O WITH DIAERESIS
04E7 ӧ \"{\cyro} CYRILLIC SMALL LETTER O WITH DIAERESIS
04E8 Ө \CYROTLD CYRILLIC CAPITAL LETTER BARRED O
04E9 ө \cyrotld CYRILLIC SMALL LETTER BARRED O
04EA Ӫ \"{\CYROTLD} CYRILLIC CAPITAL LETTER BARRED O WITH DIAERESIS
04EB ӫ \"{\cyrotld} YRILLIC SMALL LETTER BARRED O WITH DIAERESIS
04EC Ӭ \"{\CYREREV} CYRILLIC CAPITAL LETTER E WITH DIAERESIS
04ED ӭ \"{\cyreref} CYRILLIC SMALL LETTER E WITH DIAERESIS
04EE Ӯ \={\CYRU} CYRILLIC CAPITAL LETTER U WITH MACRON
04EF ӯ \={\cyru} CYRILLIC SMALL LETTER U WITH MACRON
04F0 Ӱ \"{\CYRU} CYRILLIC CAPITAL LETTER U WITH DIAERESIS
04F1 ӱ \"{\cyru} CYRILLIC SMALL LETTER U WITH DIAERESIS
04F2 Ӳ \H{\CYRU} CYRILLIC CAPITAL LETTER U WITH DOUBLE ACUTE
04F3 ӳ \H{\cyru} CYRILLIC SMALL LETTER U WITH DOUBLE ACUTE
04F4 Ӵ \"{\CYRCH} CYRILLIC CAPITAL LETTER CHE WITH DIAERESIS
04F5 ӵ \"{\cyrch} CYRILLIC SMALL LETTER HE WITH DIAERESIS
04F6 Ӷ \CYRGDSC CYRILLIC CAPITAL LETTER GHE WITH DESCENDER
04F7 ӷ \cyrgdsc CYRILLIC SMALL LETTER GHE WITH DESCENDER
04F8 Ӹ \"{\CYRERY} CYRILLIC CAPITAL LETTER YERU WITH DIAERESIS
04F9 ӹ \"{\cyrery} YRILLIC SMALL LETTER YERU WITH DIAERESIS
04FC Ӽ \CYRHHK CYRILLIC CAPITAL LETTER HA WITH HOOK
04FD ӽ \cyrhhk CYRILLIC SMALL LETTER HA WITH HOOK
05C3 ׃ \sofpasuq HEBREW PUNCTUATION SOF PASUQ
05D0 א \textalef
\hebalef
HEBREW LETTER ALEF
23
2. 3 Results reported as median (IQR) for all participants and UIC categories. 4 Values are log transformed and reported as mean ± SD. Abbreviations: UIC, Urinary iodine
concentration; BMI, body mass index; Na, not applicable.
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3.2. Urinary Iodine Concentration and Neurodevelopment
There was a positive correlation between UIC (µg/L) and UIC/creatinine (µg/g), rs = 0.54,
p < 0.001, a strong positive correlation between UIC (µg/L) and UIC~creatinine (µg/L), rs = 0.73,
p < 0.001, and even stronger positive correlation between UIC~creatinine (µg/L) and UIC/creatinine
(µg/g), rs = 0.93, p < 0.001.
Having a low UIC (µg/L) in pregnancy (lower than ~100 µg/L) was significantly associated with
poorer skills in language domains (receptive and expressive) in infancy and toddlerhood, but not with
poorer cognitive score or fine- and gross motor skills (Figure 2A–E). The adjusted associations for
both language outcomes displayed similar curve-shapes, but non-linearity was only significant for
expressive language (p = 0.003) (Figure 2C).
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statistical significance (Figure S2 and Figure S3). All analyses were repeated including only complete
cases, i.e., excluding n = 117 participants with missing information on pre-pregnancy BMI, and it did
not change the results (Figure S4 and Table S1).
3.3. Iodine Supplement use and Neurodevelopment
Maternal use of iodine-containing supplements in pregnancy was associated with poorer gross
motor skills, standardized beta = −0.18, 95% CI = −0.33, −0.03, p = 0.02 (Table 2).
Table 2. Longitudinal regressions of maternal use of iodine-containing supplement and the overall
mean of standardized scores on child neurodevelopment. Non-users of iodine-containing supplements
serve as reference group.
Iodine Supplement
Bayley III 1 n Crude Models Adjusted Models 2
B 3 95% CI p B 3 95% CI p
Cognitive score 813 0.00 −0.13, 0.13 0.98 0.02 −0.11, 0.15 0.79
Receptive language 813 0.02 −0.10, 0.14 0.79 −0.02 −0.14, 0.11 0.81
Expressive language 813 0.07 −0.05, 0.20 0.26 0.05 −0.08, 0.18 0.44
Fine motor skills 810 −0.12 −0.25, 0.02 0.093 −0.10 −0.23, 0.03 0.15
Gross motor skills 810 −0.20 −0.35, −0.05 0.010 −0.18 −0.33, −0.03 0.020
1 Bayley Scales of Infant and Toddler Development, third edition. 2 Models were adjusted for maternal age,
prepregnancy BMI, marital status, education, parity, daily smoking in pregnancy, use of supplements containing
omega-3 fatty acid in pregnancy, and child sex. 3 Standardized beta coefficient. B represents the standardized
beta, i.e., the estimated difference in mean outcome score (in standard deviations) between the exposed and the
non-exposed (to iodine supplement use).
4. Discussion
The main finding of this study is that mild to moderate ID during pregnancy may adversely
affect neurodevelopment in infancy and toddlerhood. The study population was sufficiently large
to conclude that the median UIC indicates insufficient iodine intake in this population of pregnant
women in Norway [33]. This is to our knowledge the largest and most complete assessment to date of
maternal iodine urinary status during pregnancy and its relation to repeated measures of infant and
toddler neurodevelopment.
4.1. Urinary Iodine Concentration and Neurodevelopment
We found that an insufficient iodine intake in pregnancy, reflected in a UIC below ~100 µg/L,
was associated with lower infant language skills up to 18 months. This accords with studies in
older children and suggests that inadequate iodine intake in pregnancy has consequences already
in early in life. In the ALSPAC study, Bath et al. [12] found that children of mothers with UIC
< 150 µg/g creatinine were more likely to score within the lowest quartile on verbal IQ, reading
accuracy, and reading comprehension at age 8-9 years than children of mothers with UIC ≥ 150 µg/g
creatinine. In a similar study in Australia, mild ID (i.e., UIC < 150 µg/L) in pregnancy was associated
with lower educational outcomes in children at age 9 years [34]. A prospective study from The
Netherlands reported that low maternal UIC during pregnancy (< 10th percentile) was associated with
impaired executive function in children at age four years [35]. In MoBa, Abel et al. [36] concluded that
maternal iodine intake below the Estimated Average Requirement during pregnancy (160 µg/day)
was associated with increased risk of child language delay, more behavior problems, and reduced fine
motor skills at age 3. In a recent publication from The UK Robinson et al. found a positive association
between iodine status before conception (I/Cr 108 µg/g) and child IQ [14]. The results from our study
support these findings and expand current knowledge by indicating that adverse effects on inadequate
iodine intake on neurodevelopment is detectable already in infancy.
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Why we see an effect on language skills but not cognition is unclear, and further data are needed.
A substantial body of research points to many interrelations between language development and
cognition [37]. It may be speculated that poor language skills are more easily detected at this early
age than cognitive impairment, or that language and cognition are undifferentiated at this age [30].
The fact that iodine status was found not to be significantly associated with cognition in this study
could be due to lack of power in the study (too few participants and a high degree of measurement
error on outcomes at such a young age). One can see that the cognition graph has the same shape as
the language skill graphs, but the association was not significant. Nevertheless, our findings are in
line with previous research, including Hynes et al. [38], who found that a group of adolescents had
poorer performance and continued to lag behind their peers with respect to language and literacy
development 15 years after being exposed to mild ID in pregnancy.
The associations we explored in this study were similar, but no longer statistically significant
when UIC was adjusted for creatinine. Creatinine adjustment is commonly used to remove variation in
UIC due to hydration status. However, including creatinine in the estimation of the exposure variable
might also introduce bias since creatinine excretion is not constant between individuals, but vary with
e.g., age, BMI, muscle mass/fitness level, and gestational age [6]. Consequently, creatinine-adjusted
UIC is associated with maternal characteristics that are potential predictors of the outcomes.
4.2. Iodine Supplement Use and Neurodevelopment
We did not find evidence of a protective effect of iodine supplement use in pregnancy. On the
contrary, maternal iodine supplement use was associated with lower infant gross motor skills.
This finding may be due to chance since we did not control for multiple comparisons. Since only
18% of the participants reported use of iodine-containing supplements, there was limited power to
detect differences between the groups. We assessed iodine supplement use over the past three months
before the first UIC and it covered primarily the second trimester. Ideally, we should have had data
from before pregnancy and in the first trimester. Consequently, it cannot be ruled out that iodine
supplement use was initiated too late to counteract the detrimental impact of inadequate maternal
iodine status in the most critical time of fetal brain development. Results from studies of iodine
supplement use in pregnancy in areas of mild- to moderate ID show conflicting results, and more
research is needed [39]. Our findings of no benefit are supported by recent results from in MoBa [36,40]
where it was found that the use of iodine supplements during pregnancy had no beneficial effect
on the children’s neurodevelopment. Also, in a recently published RCT from India and Thailand,
daily iodine supplementation in mildly iodine-deficient pregnant women (median UIC: 131 µg/L) had
no effect on child neurodevelopment at age 5–6 years [41]. Altogether, this suggests a superior effect of
habitual/long-term iodine intake from food, and that poor iodine intake and status before pregnancy
cannot be compensated for by iodine-containing supplements in pregnancy.
4.3. Strengths and Limitations
A major strength of this study is the relatively large study population with data on UIC,
the repeated measures of individually administered assessment of infant neurodevelopmental
outcomes, and the minimal loss to follow up. An important limitation to the study is the use of
a single spot-UIC which is not regarded as a good measure of iodine status at an individual level and
thus it limits the statistical power when exploring associations to outcomes [6,42–44]. Observational
studies tend to have a larger proportion of participants from higher socioeconomic status, introducing
selection bias. However, associations between exposures and outcomes are not necessarily biased [45].
In this study population, however, there was a considerable proportion also of low-income mothers.
Interestingly, we did not find any associations between UIC and education level or income. However,
the observational design means we cannot rule out the possibility of residual confounding.
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4.4. Implications of Findings
This study provides supporting evidence that mild to moderate ID in pregnancy impairs brain
development and should be prevented. Reduced communication skills can influence the child’s
possibilities to obtain information about the environment and is an early predictor of later school
performance and IQ [46]. Consequently, poorer communication skills may reduce the capacity for the
child to reach its developmental potential. Insufficient iodine status in pregnancy is a public health
concern and actions are urgently needed. It could be questioned whether the cut-off for median UIC
defining adequate iodine intake in pregnancy by the WHO of 150 µg/L (corresponding to an intake
of 250 µg/day) is too high [1]. Our results, and also results from MoBa [36,40], suggests that a cutoff
of UIC ~100 µg/L (or intake of ~160 µg/day) would be adequate. Recommendations for pregnant
women should not be higher than necessary since securing an adequate iodine intake for pregnant
women by food fortification may put other population groups at risk of iodine excess [47].
5. Conclusions
This study provides further evidence for a potential negative impact of insufficient iodine
status in pregnancy on child neurodevelopment. The results showed that the tipping point for
adverse developmental outcomes was UIC ~100 µg/L. Furthermore, we found no indication of a
protective effect of iodine-containing supplements used in pregnancy, however, RCTs are needed
to elucidate the impact of iodine supplement use. Preventing mild- to moderate ID in pregnant
women by securing adequate iodine status before conception is an optimal strategy, since use of
iodine containing supplements in pregnancy may be too late to counteract the detrimental effects of
inadequate iodine intake.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/9/1270/s1,
Method S1: Imputation; Table S1: Longitudinal regressions of maternal use of iodine-containing supplement
and the overall mean of standardized scores on child neurodevelopment. Non-users of iodine-containing
supplements serve as reference group. Complete case analysis; Figure S1: UIC µg/L in pregnancy and the overall
mean of standardized neurodevelopmental scores in infancy and toddlerhood. Panel A-E represent different
neurodevelopmental domains, A: Cognitive score; B: Receptive language; C: Expressive language; D: Fine motor
skills; E Gross motor skills. The histogram in panel F illustrates the distribution of urinary iodine concentration
(µg/L) in the population. Associations were modelled flexibly by use of restricted cubic splines (three knot
positions, at percentiles 10, 50, and 90 of UIC). Solid lines represent estimated means across measurement
occasions, and the grey areas illustrate 95% robust confidence intervals (CI). P-values for the overall associations of
UIC and outcomes were calculated by testing all spline-coefficients equal to zero, and non-linearity by testing the
second spline coefficient equal to zero. Models are crude; Figure S2: UIC~Cr, µg/l in pregnancy and the overall
mean of standardized neurodevelopmental scores in infancy and toddlerhood. Panel A-E represent different
neurodevelopmental domains, A: Cognitive score; B: Receptive language; C: Expressive language; D: Fine motor
skills; E Gross motor skills. The histogram in panel F illustrates the distribution of urinary iodine concentration
(µg/L) in the population. Associations were modelled flexibly by use of restricted cubic splines (three knot
positions, at percentiles 10, 50, and 90 of UIC). Solid lines represent estimated means across measurement
occasions, and the grey areas illustrate 95% robust confidence intervals (CI). P-values for the overall associations
of UIC and outcomes were calculated by testing all spline-coefficients equal to zero, and non-linearity by testing
the second spline coefficient equal to zero. Models are crude; Figure S3: UIC, µg/g creatinine and the overall
mean of standardized neurodevelopmental scores in infancy and toddlerhood. Panel A-E represent different
neurodevelopmental domains, A: Cognitive score; B: Receptive language; C: Expressive language; D: Fine motor
skills; E Gross motor skills. The histogram in panel F illustrates the distribution of UIC (µg/g) in the population.
Associations were modelled flexibly by use of restricted cubic splines (three knot positions, at percentiles 10, 50,
and 90 of UIC). Solid lines represent estimated means across measurement occasions, and the grey areas illustrate
95% robust confidence intervals (CI). P-values for the overall associations of UIC and outcomes were calculated
by testing all spline-coefficients equal to zero, and non-linearity by testing the second spline coefficient equal to
zero. Models are adjusted for maternal age, prepregnancy BMI, marital status, education, parity, daily smoking in
pregnancy, and child sex. The solid line is the dose–response curve; the grey area represents the 95% confidence
interval; Figure S4: UIC µg/L in pregnancy and mean neurodevelopmental scores estimated in mixed models over
sampling occasions at child age 6, 12, and 18 months. Panel A-E represent different neurodevelopmental domains,
A: Cognitive score; B: Receptive language; C: Expressive language; D: Fine motor skills; E: Gross motor skills.
The histogram in panel F illustrates the distribution of urinary iodine concentration (µg/L) in the population.
Associations were modelled flexibly by use of restricted cubic splines (three knot positions, at percentiles 10, 50,
and 90 of UIC). Solid lines represent estimated means across measurement occasions, and the grey areas illustrate
95% robust confidence intervals (CI). P-values for the overall associations of UIC and outcomes were calculated
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by testing all spline-coefficients equal to zero, and non-linearity by testing the second spline coefficient equal to
zero. Models are adjusted for maternal age, prepregnancy BMI, marital status, education, parity, daily smoking in
pregnancy, and child sex. Complete case analysis
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